GSK logo

GSK (GSK) Long Term Debt

Annual Long Term Debt

$19.37 B
-$1.25 B-6.04%

31 December 2023

GSK Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Debt

$17.72 B
+$551.06 M+3.21%

30 September 2024

GSK Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GSK Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.0%-9.2%
3 y3 years-39.3%-36.3%
5 y5 years-24.7%-41.9%

GSK Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-39.3%at low-53.8%+3.2%
5 y5 years-39.3%at low-53.8%+3.2%
alltimeall time-39.3%>+9999.0%-53.8%>+9999.0%

GSK Long Term Debt History

DateAnnualQuarterly
Sept 2024
-
$17.72 B(+3.2%)
June 2024
-
$17.17 B(-10.3%)
Mar 2024
-
$19.13 B(-1.2%)
Dec 2023
$19.37 B(-6.0%)
$19.37 B(-0.7%)
Sept 2023
-
$19.51 B(-0.5%)
June 2023
-
$19.62 B(-4.8%)
Mar 2023
-
$20.61 B(-0.0%)
Dec 2022
$20.62 B(-25.7%)
$20.62 B(-4.5%)
Sept 2022
-
$21.58 B(-5.3%)
June 2022
-
$22.78 B(-40.7%)
Mar 2022
-
$38.39 B(+38.3%)
Dec 2021
$27.76 B(-13.0%)
$27.76 B(-0.3%)
Sept 2021
-
$27.84 B(-1.6%)
June 2021
-
$28.29 B(-10.7%)
Mar 2021
-
$31.68 B(-0.8%)
Dec 2020
$31.92 B(+3.2%)
$31.92 B(+6.4%)
Sept 2020
-
$30.02 B(-5.2%)
June 2020
-
$31.67 B(+3.5%)
Mar 2020
-
$30.60 B(-1.1%)
Dec 2019
$30.93 B(+20.2%)
$30.93 B(+1.3%)
Sept 2019
-
$30.52 B(+3.3%)
June 2019
-
$29.54 B(-3.0%)
Mar 2019
-
$30.45 B(+18.4%)
Dec 2018
$25.72 B(+33.4%)
$25.72 B(-20.4%)
Sept 2018
-
$32.32 B(+0.5%)
June 2018
-
$32.15 B(+63.7%)
Mar 2018
-
$19.64 B(+1.9%)
Dec 2017
$19.28 B(+7.0%)
$19.28 B(+0.4%)
Sept 2017
-
$19.20 B(+20.4%)
June 2017
-
$15.95 B(-12.4%)
Mar 2017
-
$18.22 B(+1.1%)
Dec 2016
$18.01 B(-20.7%)
$18.01 B(-9.8%)
Sept 2016
-
$19.96 B(-1.8%)
June 2016
-
$20.32 B(-10.2%)
Mar 2016
-
$22.63 B(-0.3%)
Dec 2015
$22.70 B(-7.9%)
$22.70 B(-0.8%)
Sept 2015
-
$22.89 B(-0.9%)
June 2015
-
$23.11 B(+2.5%)
Mar 2015
-
$22.54 B(-8.6%)
Dec 2014
$24.66 B(-3.3%)
$24.66 B(+11.5%)
Sept 2014
-
$22.12 B(-10.5%)
June 2014
-
$24.71 B(-3.5%)
Mar 2014
-
$25.60 B(+0.5%)
Dec 2013
$25.49 B(+7.5%)
$25.49 B(+0.7%)
Sept 2013
-
$25.31 B(+1.8%)
June 2013
-
$24.86 B(-5.4%)
Mar 2013
-
$26.29 B(+10.9%)
Dec 2012
$23.71 B(+26.1%)
$23.71 B(+9.6%)
Sept 2012
-
$21.63 B(+2.7%)
June 2012
-
$21.06 B(+10.1%)
Mar 2012
-
$19.13 B(+1.8%)
Dec 2011
$18.80 B(-17.7%)
$18.80 B(-15.1%)
Sept 2011
-
$22.16 B(-3.1%)
June 2011
-
$22.87 B(-4.0%)
Mar 2011
-
$23.83 B(+4.3%)
Dec 2010
$22.86 B
$22.86 B(-2.5%)
Sept 2010
-
$23.45 B(+5.7%)
June 2010
-
$22.19 B(-4.0%)
DateAnnualQuarterly
Mar 2010
-
$23.10 B(-3.4%)
Dec 2009
$23.91 B(+7.2%)
$23.91 B(-0.6%)
Sept 2009
-
$24.05 B(+11.8%)
June 2009
-
$21.51 B(-0.7%)
Mar 2009
-
$21.67 B(-2.9%)
Dec 2008
$22.31 B(+58.8%)
$22.31 B(-2.2%)
Sept 2008
-
$22.81 B(-8.9%)
June 2008
-
$25.04 B(+55.6%)
Mar 2008
-
$16.10 B(+14.6%)
Dec 2007
$14.05 B(+50.4%)
$14.05 B(+40.7%)
Sept 2007
-
$9.99 B(-1.0%)
June 2007
-
$10.09 B(+7.1%)
Mar 2007
-
$9.42 B(+0.8%)
Dec 2006
$9.34 B(+3.1%)
$9.34 B(+2.8%)
Sept 2006
-
$9.08 B(+0.8%)
June 2006
-
$9.02 B(-1.9%)
Mar 2006
-
$9.19 B(+1.4%)
Dec 2005
$9.06 B(+7.8%)
$9.06 B(-1.4%)
Sept 2005
-
$9.20 B(-1.4%)
June 2005
-
$9.33 B(+21.0%)
Mar 2005
-
$7.71 B(-8.2%)
Dec 2004
$8.40 B(+28.9%)
$8.40 B(-6.7%)
Sept 2004
-
$9.01 B(+0.9%)
June 2004
-
$8.93 B(+34.8%)
Mar 2004
-
$6.63 B(+1.6%)
Dec 2003
$6.52 B(+30.8%)
$6.52 B(+5.9%)
Sept 2003
-
$6.16 B(-2.6%)
June 2003
-
$6.32 B(+35.7%)
Mar 2003
-
$4.66 B(-6.6%)
Dec 2002
$4.98 B(+62.9%)
$4.98 B(+18.5%)
Sept 2002
-
$4.21 B(+14.0%)
June 2002
-
$3.69 B(+5.1%)
Mar 2002
-
$3.51 B(+14.8%)
Dec 2001
$3.06 B(+17.2%)
$3.06 B(+37.0%)
Sept 2001
-
$2.23 B(+1.3%)
June 2001
-
$2.20 B(-5.5%)
Mar 2001
-
$2.33 B(-10.6%)
Dec 2000
$2.61 B(+28.2%)
$2.61 B(-10.1%)
Sept 2000
-
$2.91 B(-1.6%)
June 2000
-
$2.95 B(-2.1%)
Mar 2000
-
$3.01 B(+48.0%)
Dec 1999
$2.04 B(-31.8%)
$2.04 B(-20.1%)
June 1999
-
$2.55 B(-14.5%)
Dec 1998
$2.98 B(-2.1%)
$2.98 B(-0.3%)
June 1998
-
$2.99 B(-1.9%)
Dec 1997
$3.05 B(+5.6%)
$3.05 B(+5.6%)
Dec 1996
$2.89 B(+27.0%)
$2.89 B(-44.5%)
Dec 1995
$2.27 B(-56.3%)
-
June 1995
-
$5.20 B(+1141.0%)
June 1995
$5.20 B(+1141.0%)
-
June 1994
$419.02 M(+31.0%)
$419.02 M(+31.0%)
June 1993
$319.84 M(+22.9%)
$319.84 M(+22.9%)
June 1992
$260.30 M(+14.6%)
$260.30 M(+14.6%)
June 1991
$227.11 M(+196.1%)
$227.11 M(+196.1%)
June 1990
$76.69 M(+54.6%)
$76.69 M(+54.6%)
June 1989
$49.59 M(+141.8%)
$49.59 M(+141.8%)
June 1988
$20.51 M(-2.0%)
$20.51 M(-2.0%)
June 1987
$20.93 M(+36.7%)
$20.93 M(+36.7%)
June 1986
$15.31 M
$15.31 M

FAQ

  • What is GSK annual long term debt?
  • What is the all time high annual long term debt for GSK?
  • What is GSK annual long term debt year-on-year change?
  • What is GSK quarterly long term debt?
  • What is the all time high quarterly long term debt for GSK?
  • What is GSK quarterly long term debt year-on-year change?

What is GSK annual long term debt?

The current annual long term debt of GSK is $19.37 B

What is the all time high annual long term debt for GSK?

GSK all-time high annual long term debt is $31.92 B

What is GSK annual long term debt year-on-year change?

Over the past year, GSK annual long term debt has changed by -$1.25 B (-6.04%)

What is GSK quarterly long term debt?

The current quarterly long term debt of GSK is $17.72 B

What is the all time high quarterly long term debt for GSK?

GSK all-time high quarterly long term debt is $38.39 B

What is GSK quarterly long term debt year-on-year change?

Over the past year, GSK quarterly long term debt has changed by -$1.79 B (-9.17%)